Eldecalcitol: a review of its use in the treatment of osteoporosis (Q34214638)

31 July 2017

1 reference

title

Eldecalcitol: a review of its use in the treatment of osteoporosis (English)

1 reference

31 July 2017

0 references

Mark Sanford

1 reference

31 July 2017

Paul L McCormack

series ordinal

1 reference

31 July 2017

publication date

1 September 2011

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

1755-1770

1 reference

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Approaches to the targeting of treatment for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Epidemiology of osteoporosis in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Male osteoporosis: deadly, but ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Diagnosis of osteoporosis and assessment of fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Diagnostic criteria for primary osteoporosis: year 2000 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

What is new in vitamin D: 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

High Prevalence of Vitamin D Inadequacy and Implications for Health

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Progress in osteoporosis and fracture prevention: focus on postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Rationale for active vitamin D and analogs in the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Atypical fractures as a potential complication of long-term bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

Osteoporosis and Fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11206790-000000000-00000

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures — A randomized, active comparator, double-blind study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21902297

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Synthesis and biological evaluation of a 3-positon epimer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21902297

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21902297

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2165/11206790-000000000-00000

1 reference

Dimensions Publication ID

31 July 2017

1030296649

0 references

1 reference